- Home
- KNSA vs FCF Comparison
KNSA vs FCF Comparison
Compare KNSA & FCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- FCF
- Stock Information
- Founded
- KNSA 2015
- FCF 1934
- Country
- KNSA United Kingdom
- FCF United States
- Employees
- KNSA N/A
- FCF N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- FCF Major Banks
- Sector
- KNSA Health Care
- FCF Finance
- Exchange
- KNSA Nasdaq
- FCF Nasdaq
- Market Cap
- KNSA 1.9B
- FCF 1.8B
- IPO Year
- KNSA 2018
- FCF N/A
- Fundamental
- Price
- KNSA $35.71
- FCF $17.89
- Analyst Decision
- KNSA Strong Buy
- FCF Buy
- Analyst Count
- KNSA 6
- FCF 7
- Target Price
- KNSA $40.83
- FCF $19.00
- AVG Volume (30 Days)
- KNSA 439.9K
- FCF 480.2K
- Earning Date
- KNSA 10-28-2025
- FCF 10-28-2025
- Dividend Yield
- KNSA N/A
- FCF 3.00%
- EPS Growth
- KNSA N/A
- FCF N/A
- EPS
- KNSA 0.07
- FCF 1.30
- Revenue
- KNSA $529,332,000.00
- FCF $454,628,000.00
- Revenue This Year
- KNSA $37.21
- FCF $17.70
- Revenue Next Year
- KNSA $11.99
- FCF $8.50
- P/E Ratio
- KNSA $539.78
- FCF $13.86
- Revenue Growth
- KNSA 56.18
- FCF N/A
- 52 Week Low
- KNSA $17.82
- FCF $13.54
- 52 Week High
- KNSA $35.82
- FCF $19.96
- Technical
- Relative Strength Index (RSI)
- KNSA 72.49
- FCF 65.54
- Support Level
- KNSA $33.25
- FCF $17.35
- Resistance Level
- KNSA $34.16
- FCF $17.96
- Average True Range (ATR)
- KNSA 0.83
- FCF 0.31
- MACD
- KNSA 0.07
- FCF 0.06
- Stochastic Oscillator
- KNSA 95.59
- FCF 76.83
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About FCF First Commonwealth Financial Corporation
First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.